These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11588)

  • 21. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic bone marrow chimerism in germfree mice. 1. Prevention of spontaneous leukemia in AKR mice.
    Pollard M; Truitt RL
    Proc Soc Exp Biol Med; 1973 Nov; 144(2):659-65. PubMed ID: 4583624
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 24. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
    Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
    J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of long-term cultured bone marrow cells.
    Spooncer E; Dexter TM
    Transplantation; 1983 Jun; 35(6):624-7. PubMed ID: 6135264
    [No Abstract]   [Full Text] [Related]  

  • 26. Failure to detect anti-group-specific murine leukemia virus activity in tetraparental AKR-CBA chimeras.
    Barnes RD; Tuffrey MA; Bourne RC
    Cancer Res; 1975 Oct; 35(10):2699-703. PubMed ID: 168964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative and qualitative study of myeloid chloroleukemia virus based on the resistance phenomenon.
    Prigozhina EL; Stavrovskaya AA
    Fed Proc Transl Suppl; 1965; 24(5):929-32. PubMed ID: 4284566
    [No Abstract]   [Full Text] [Related]  

  • 29. Allogeneic bone marrow chimerism in germfree mice. 3. Therapy of leukemic AKR mice.
    Truitt RL; Pollard M; Srivastava KK
    Proc Soc Exp Biol Med; 1974 May; 146(1):153-8. PubMed ID: 4597165
    [No Abstract]   [Full Text] [Related]  

  • 30. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras.
    Shih CC; Truitt RL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2664-7. PubMed ID: 2950639
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolonged survival of AKR mice following allogeneic bone marrow transplantation.
    Rose WC; Bortin MM; Saltzstein EC
    Experientia; 1974 Sep; 30(9):1085-6. PubMed ID: 4153447
    [No Abstract]   [Full Text] [Related]  

  • 32. Sites of synthesis of murine RNA tumor virus (oncornavirus) group-specific antigens.
    Pattengale PK; Ikeda H; Thorbecke GJ
    Cancer Res; 1974 Apr; 34(4):810-7. PubMed ID: 4360841
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.
    Johnson BD; McCabe C; Hanke CA; Truitt RL
    J Immunol; 1995 May; 154(10):5542-54. PubMed ID: 7730653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autogenous immunity to mouse mammary tumor virus in mouse strains of high and low mammary tumor incidence.
    Ihle JN; Arthur LO; Fine DL
    Cancer Res; 1976 Aug; 36(8):2840-4. PubMed ID: 179709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymic epithelium is programmed to induce preleukemic changes in retrovirus expression and thymocyte differentiation in leukemia susceptible mice: studies on bone marrow and thymic chimeras.
    Zielinski CC; Waksal SD; Datta SK
    J Immunol; 1982 Aug; 129(2):882-9. PubMed ID: 6123535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A discrepancy in XC and oncogenicity assays for murine leukemia virus in AKR mice.
    Hays EF; Vredevoe DL
    Cancer Res; 1977 Mar; 37(3):726-30. PubMed ID: 189912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AKR mouse leukemia cells in tissue culture. I. Establishment of leukemic cell line AKR 87 and its morphologic and biologic characteristics.
    Duś D
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):713-25. PubMed ID: 187140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.